Unlearn is at the forefront of AI innovation in medicine, working to speed up clinical drug development and reduce the reliance on trial and error by leveraging advanced artificial intelligence.
For more details, visit our contact us page.
Company Name: Unlearn.ai
Address: 303 2nd Street, Suite N460, San Francisco, CA 94107
For more information, please visit our about us page.
Check out our YouTube channel: Unlearn YouTube Channel
Connect with us on LinkedIn: Unlearn LinkedIn
Follow us on Twitter: Unlearn Twitter
We are advancing AI to power the future of medicine by developing and deploying AI to accelerate clinical drug development and eliminate trial and error in medicine.
To use our website, follow these steps:
1. Learn about digital twins and how they enhance clinical trials
2. Download our whitepaper on positioning clinical trials with digital twins for regulatory success
3. Join our team and read our publications on engineering the future of medicine with artificial intelligence
A patient’s digital twin is a comprehensive forecast of their future health. We invent and deploy new types of generative models trained on extensive patient-level data from previous studies.
Digital twins enhance clinical trials by calculating prognostic scores for each patient in a randomized clinical trial using their digital twins. Adjusting for these scores in the analysis increases power while adhering to guidance from regulatory agencies.